Ruptured Achilles Tendon Clinical Trial
— AchillesRCTOfficial title:
Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon: A Multi-centered Randomized Control Trial Using Standardized Objective and Subjective Outcome Measurement to Determine Rerupture Rate.
| NCT number | NCT01711307 |
| Other study ID # | Version1 |
| Secondary ID | |
| Status | Terminated |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 1, 2012 |
| Est. completion date | June 30, 2020 |
| Verified date | July 2020 |
| Source | Nova Scotia Health Authority |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The proposed trial is a multi-centre prospective randomized controlled trial comparing outcomes of patients with acute Achilles tendon ruptures treated either non-operatively or with open operative tendon repair. All patients will undergo accelerated functional rehabilitation. The primary outcome measure is Achilles tendon re-rupture rate.
| Status | Terminated |
| Enrollment | 220 |
| Est. completion date | June 30, 2020 |
| Est. primary completion date | December 31, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Complete mid-substance rupture of the Achilles tendon as diagnosed on clinical exam - Present for initial assessment and treatment with application of a plantar-flexed cast within 48 hours of their injury. - Referred to one of the participating orthopaedics surgeons in a timely fashion so as to allow for further treatment (operative repair or initiation of the rehabilitation protocol) within 14 days of their injury. Exclusion Criteria: - Open Achilles injury - Achilles injury that is not a mid-substance tendon injury - Any additional injury to the ipsilateral lower extremity - Contraindication to surgery or anesthetic - (Physical or mental) that may interfere with compliance with the rehabilitation protocol - Any known factor for increased risk of Achilles tendon rupture (i.e. diabetes mellitus, immunosuppressive therapy including local or systemic steroids, and fluoroquinolone use). |
| Country | Name | City | State |
|---|---|---|---|
| Canada | Halifax Infirmary | Halifax | Nova Scotia |
| Lead Sponsor | Collaborator |
|---|---|
| Mark Glazebrook | Nova Scotia Health Authority |
Canada,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Operative vs non operative Treatment of acute ruptures of Achilles tendon. | The primary outcome measure is Achilles tendon re-rupture rate | 1 year | |
| Secondary | Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon | 1. The Achilles tendon Total Rupture Score (ATRS) | 2 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04114708 -
MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis
|
N/A |